Cite
Immuno-PET of the hepatocyte growth factor receptor Met using the 1-armed antibody onartuzumab
MLA
Lawrence P. Szajek, et al. “Immuno-PET of the Hepatocyte Growth Factor Receptor Met Using the 1-Armed Antibody Onartuzumab.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 53, no. 10, Aug. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8089c53be1b16c98324cccaf94c939cb&authtype=sso&custid=ns315887.
APA
Lawrence P. Szajek, Donald P. Bottaro, Elaine M. Jagoda, Jeffrey Tinianow, Kristen Raffensperger, Lixin Lang, Jan Marik, Stephanie Histed, Fabiola Cecchi, Veerendra Bhadrasetty, Gabriela Kramer-Marek, Chang Paik, Esther Mena, Lauren T Rosenblum, Peter L. Choyke, Joe-Marie Jose-Dizon, Mark C. Williams, & Mark Merchant. (2012). Immuno-PET of the hepatocyte growth factor receptor Met using the 1-armed antibody onartuzumab. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 53(10).
Chicago
Lawrence P. Szajek, Donald P. Bottaro, Elaine M. Jagoda, Jeffrey Tinianow, Kristen Raffensperger, Lixin Lang, Jan Marik, et al. 2012. “Immuno-PET of the Hepatocyte Growth Factor Receptor Met Using the 1-Armed Antibody Onartuzumab.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 53 (10). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8089c53be1b16c98324cccaf94c939cb&authtype=sso&custid=ns315887.